Loading
Medical oncologist and cancer geneticist who chairs the independent expert committee that recommends which medicines Australia subsidises through the Pharmaceutical Benefits Scheme.
Professor Robyn Ward AM is Chair of the Pharmaceutical Benefits Advisory Committee (PBAC), the independent expert body appointed by the Australian Government to recommend new medicines for listing on the Pharmaceutical Benefits Scheme. She is Deputy Vice-Chancellor (Research and Enterprise) and Senior Vice-President of Monash University. Her expertise spans medical oncology, cancer genetics and health technology assessment, and she was made a Member of the Order of Australia for service to medical research and patient care in oncology.
Shares the tags leadership, clinician-scientist, health-technology-assessment, drug-reimbursement.
Shares Health technology assessment (HTA), reimbursement and QALYs and the tags leadership, clinician-scientist.
Shares Health technology assessment (HTA), reimbursement and QALYs and the tag leadership.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.
Shares the tags leadership, clinician-scientist.